Lombard Medical Technologies (LSE:LMT) FCF Margin % : -197.10% (As of Dec. 2012)

View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Lombard Medical Technologies's Free Cash Flow for the six months ended in Dec. 2012 was £-7.67 Mil. Lombard Medical Technologies's Revenue for the six months ended in Dec. 2012 was £3.89 Mil. Therefore, Lombard Medical Technologies's FCF Margin % for the quarter that ended in Dec. 2012 was -197.10%.

As of today, Lombard Medical Technologies's current FCF Yield % is 0.00%.

The historical rank and industry rank for Lombard Medical Technologies's FCF Margin % or its related term are showing as below:

LSE:LMT' s FCF Margin % Range Over the Past 10 Years
Min: -197.1 Med: 0 Max: 0
Current: -197.1

LSE:LMT's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -7.1 vs LSE:LMT: -197.10

Lombard Medical Technologies FCF Margin % Historical Data

The historical data trend for Lombard Medical Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies FCF Margin % Chart

Lombard Medical Technologies Annual Data

Trend

Sep02

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

FCF Margin %

Get a 7-Day Free Trial

-568.30

-242.91

-257.31

-262.64

-197.10

Lombard Medical Technologies Semi-Annual Data
	Sep02	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
FCF Margin %	Get a 7-Day Free Trial					-568.30	-242.91	-257.31	-262.64	-197.10

Competitive Comparison of Lombard Medical Technologies's FCF Margin %

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lombard Medical Technologies's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's FCF Margin % falls into.

Lombard Medical Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Lombard Medical Technologies's FCF Margin for the fiscal year that ended in Dec. 2012 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2012 )	/	Revenue (A: Dec. 2012 )
	=	-7.667	/	3.89
	=	-197.10 %

Lombard Medical Technologies's FCF Margin for the quarter that ended in Dec. 2012 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2012 )	/	Revenue (Q: Dec. 2012 )
	=	-7.667	/	3.89
	=	-197.10 %

Lombard Medical Technologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lombardmedical.com

Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.